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Abstract
Background: Resectable adenocarcinomas in the pancreatic head, by definition "periampullary",
originate from ampullary, duodenal, biliary, or ductal pancreatic epithelium. Typically, periampullary
adenocarcinomas have either intestinal or pancreatobiliary type of differentiation, and the type of
differentiation might be prognostically more important than the anatomic site of origin. The aim of
the study was to determine whether the histologic type of differentiation is an independent
prognostic factor in periampullary adenocarcinoma, and whether tumour origin predicts the
prognosis in pancreatobiliary type carcinomas independently of resection margin involvement,
tumour size, nodal involvement, perineural and vascular infiltration, and degree of differentiation.
Methods: Histopathologic variables in 114 consecutively resected periampullary adenocarcinomas
of pancreatobiliary (n = 67) and intestinal (n = 47) type differentiation were evaluated using a
standardized, systematic protocol for evaluation of the resected specimen (study group). Histologic
type of differentiation and tumour origin were compared as predictors of survival, and the results
were validated by comparison with a historical control group consisting of 99 consecutive
pancreaticoduodenectomies performed before standardization of histopathologic evaluation.
Associations between histopathologic variables were evaluated by Chi-square and Mann-Whitney
tests. Survival was estimated by the Kaplan-Meier method, comparing curves using log-rank test,
and by univariate and multivariable Cox regression analysis.
Results: Both in the study group (n = 114) and in the historical control group (n = 99), the
histologic type of differentiation independently predicted survival, while tumour origin predicted
survival only in univariate analysis. Independent adverse predictors of survival in the study group
were pancreatobiliary type differentiation (p < 0.001; HR 3.1; CI 1.8–5.1), regional lymph node
involvement (p < 0.001; HR 2.5; CI 1.5–4.4), vessel involvement (p = 0.012; HR 1.9; CI 1.2–3.1),
Published: 11 June 2008
BMC Cancer 2008, 8:170 doi:10.1186/1471-2407-8-170
Received: 7 July 2007
Accepted: 11 June 2008
This article is available from: http://www.biomedcentral.com/1471-2407/8/170
© 2008 Westgaard et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
Page 2 of 11
(page number not for citation purposes)
and increasing tumour diameter (measured in cm, p = 0.011; HR 1.3; CI 1.1–1.5). For
pancreatobiliary differentiated adenocarcinomas (n = 67), lymph node status, vessel involvement,
and tumour diameter remained independent prognostic factors, while tumour origin did not
independently predict the prognosis due to significant association with tumour size (p < 0.001) and
lymph node involvement (p = 0.004).
Conclusion: Pancreatobiliary versus intestinal type of differentiation independently predicts poor
prognosis after pancreaticoduodenectomy for periampullary adenocarcinoma. Lymph node
involvement, vessel infiltration, and increasing tumour diameter are adverse predictors of survival
in tumours with pancreatobiliary differentiation.
Background
Resectable primary adenocarcinomas located in the pan-
creatic head may derive from the pancreas, the ampulla,
the distal bile duct, or the duodenum. Collectively, these
tumours may be referred to as "periampullary" adenocar-
cinomas, of which those originating from the pancreas
have the worst prognosis [1]. The histopathologic and
biologic features associated with ductal pancreatic adeno-
carcinoma are different from non-pancreatic periampul-
lary tumours [2], and it has thus been customary to
consider these four subtypes of periampullary adenocarci-
noma as separate entities.
The precise origin of a periampullary adenocarcinoma is
often difficult to determine even with standardized his-
topathologic evaluation, particularly if the tumour is large
and involves more than one potential site of origin [3-8].
Tumour destruction of normal periampullary anatomy
[9], and presence of epithelial dysplasia in more than a
single periampullary compartment, occurs frequently.
Data in reports from a single subtype of periampullary
adenocarcinoma may be confounded by inadvertent
inclusion of tumours from other subtypes [6]. For exam-
ple, inadequate exclusion of ampullary carcinomas from
series of ductal pancreatic adenocarcinoma may lead to
overestimation of long-term survival [10].
In addition to the commonly evaluated histopathologic
factors, the histologic type of differentiation has been
shown to have biologic and prognostic relevance for amp-
ullary adenocarcinoma [6,7,11-14]. Kimura et al [13]
were the first to demonstrate that adenocarcinomas origi-
nating in the ampulla of Vater may be classified as having
either "intestinal" or "pancreatobiliary" type of differenti-
ation, of which patients with the latter type consistently
have been shown to have a worse prognosis [6,7,11-14].
This classification scheme is now widely accepted for
ampullary adenocarcinoma and has also been suggested
for extrahepatic bile duct carcinoma [15] and ductal pan-
creatic adenocarcinoma [16], but has not, to our knowl-
edge, been applied previously as a basis for analysis of
prognostic factors after periampullary adenocarcinoma
resections. In the present study, we hypothesized that an
evaluation of the histologic type of differentiation could
independently predict the prognosis after periampullary
resections and possibly give more precise information
about patient prognosis than evaluation of tumour origin.
Methods
Patients
Permission for the study was obtained by the National
Committees for Research Ethics in Norway. The patients
included in the study comprised all patients (n = 213)
with primary periampullary adenocarcinoma who under-
went a pancreaticoduodenectomy with curative intent
between 1980 and 2004 at Rikshospitalet University Hos-
pital, a third-level referral hospital. In January 1998, the
procedure for histopathologic reporting changed from a
non-standardized procedure to a standardized procedure,
in particular with respect to assessment of resection mar-
gins and tumour origin. Patients resected before and after
the first of January 1998 were therefore assigned to a his-
torical control group and a study group, respectively.
From 1998 to 2004 (study group), a total of 161 patients
underwent pancreaticoduodenectomy, of which 114
patients had primary adenocarcinoma with macroscopi-
cally free margins (R0 or R1 resections). Excluded cases
comprised patients with benign lesions (n = 22), neuroen-
docrine tumours (n = 9), invasive IPMN (n = 4), second-
ary carcinoma (n = 6), acinar cell carcinoma (n = 1),
adenosquamous carcinoma (n = 1), and non-curative
resection (i.e. macroscopic residual tumour, R2 resection;
n = 4). Histopathologic features were analyzed in order to
determine (1) whether the histologic type of differentia-
tion is an independent prognostic factor in periampullary
adenocarcinoma, and (2) to evaluate predictors of poor
prognosis in the subgroup of patients that had a pancrea-
tobiliary differentiated periampullary tumour.
Among the 114 patients in the study group, 82 were dead
by the end of the study and the remaining 32 were fol-
lowed for a median of 5.8 years (range 2.4–9.3). In the
subgroup of patients with pancreatobiliary type adenocar-
cinoma, 58 (of 67) were dead by the end of the study, and
the remaining 9 patients were followed median 6.1 yearsBMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
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(range 3.5–8.7). The relatively many deaths and long fol-
low-up time for the censored cases thus permitted a sub-
group analysis of pancreatobiliary cases. Perioperative
death (in-hospital death or death within 30 days of oper-
ation) was 3.5% (4/114) in the study group, among
which three patients had ampullary tumour (3/41) and
one had tumour originating in ductal pancreatic tissue.
The patients resected between 1980 and 1997 (historical
control group, n = 99) provided a separate dataset in
which to validate the main conclusions from the study
group analysis. Tumour origin and differentiation type
was compared in the two datasets obtained by standard-
ized (study group) and non-standardized (historical con-
trol group) histopathologic evaluation, respectively. In
the historical control group, 89 (of 99) patients were dead
by the end of the study. The remaining 10 patients were
followed median 12.4 years (range 9.4–20.8). In the sub-
group of patients with pancreatobiliary type adenocarci-
noma, 69 (of 73) were dead by the end of the study, and
the remaining 4 patients were followed median 13.5 years
(range 10.4–20.8). Perioperative death was 4.0% (4/99)
in the historical control group. Cases with perioperative
death were included in the survival analyses. No patients
were lost to follow-up. Data from this series has been
reported previously [12].
Histopathologic assessment of specimens
In the study group, histopathologic factors were prospec-
tively registered by routine examination according to a
standardized, systematic protocol, and reevaluated retro-
spectively. The evaluated histopathologic factors were
tumour origin, histopathologic type of differentiation, pT
stage, maximum tumour diameter, resection margin
involvement (with special attention to the retroperitoneal
margin), perineural and vascular infiltration, regional
lymph node involvement, and degree of differentiation.
Approximately 15 tissue samples were taken from each
specimen including whole-mount blocks for most cases. A
section parallel to the ampulla, distal bile duct, pancreatic
duct, and parallel to the longitudinal duodenal axis was
made in order to demonstrate the tumour's relation to
each of these sites of potential tumour origin. The cancer
origin was determined by tumour location relative to duc-
tal anatomy and duodenal and pancreatic parenchyma,
and by associated epithelial dysplasia or in situ neoplasia.
Macroscopic pictures were also taken in selected cases.
The histologic type of differentiation was classified
according to the criteria first suggested by Kimura et al
[13], later revised by Albores-Saavedra et al [7] (figure 1).
In brief, pancreatobiliary tumours typically have simple or
branching glands and small solid nests of cells sur-
rounded by a desmoplastic stroma, have cuboideal to low
columnar epithelium arranged in a single layer without
nuclear pseudostratification, and the nuclei are rounded
but with marked variation in size and shape from one cell
to the next. Intestinal tumours typically resemble colon
cancer, may consist of solid nests with cribriform areas,
The two dominant types of histologic differentiation in periampullary adenocarcinomas: (A) The pancreatobiliary type typically  has simple or branching glands and small solid nests of cells surrounded by a desmoplastic stroma, and cuboideal to low colum- nar epithelium arranged in a single layer without nuclear pseudostratification, the nuclei rounded but with marked variation in  size and shape from one cell to the next Figure 1
The two dominant types of histologic differentiation in periampullary adenocarcinomas: (A) The pancreatobiliary 
type typically has simple or branching glands and small solid nests of cells surrounded by a desmoplastic stroma, and cuboideal 
to low columnar epithelium arranged in a single layer without nuclear pseudostratification, the nuclei rounded but with marked 
variation in size and shape from one cell to the next. (B) The intestinal type typically resembles colon cancer, may consist of 
solid nests with cribriform areas, has tall and often pseudostratified columnar epithelium with oval nuclei located in the more 
basal aspects of the cytoplasm, and there may also often be presence of mucin.BMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
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have tall and often pseudostratified columnar epithelium
with oval nuclei located in the more basal aspects of the
cytoplasm, and there may also often be presence of
mucin. Cases with mixed type differentiation were classi-
fied according to the dominant pattern, without perform-
ing cut-off optimalization prior to classification [17]. All
tumours were assigned to one of these two histologic
types of differentiation using this approach. In the histor-
ical control group (n = 99), cases with mixed type differ-
entiation were identified (n = 13; 7 predominantly
pancreatobiliary and 6 predominantly intestinal), and
survival was compared between cases with mixed and sin-
gle type of histologic differentiation in each group with
respect to the predominant histologic pattern of differen-
tiation. Patients with mixed type of differentiation had the
same prognosis as patients with only the predominant
type, eg. with only pancreatobiliary (p = 0.35) or only
intestinal (p = 0.21) type of differentiation, respectively,
thus indicating that classification based on the predomi-
nant pattern is applicable.
For both tumour origin and histologic type of differentia-
tion, the prospective registrations were reevaluated inde-
pendently by two experienced pathologists, a routine
pathologist (ST) and a senior pathologist (OPFC). The
routine pathologist reviewed only the microscopic slides
and was blinded towards clinical and macroscopic data,
while the senior pathologist also considered this informa-
tion when determining the anatomic site of tumour ori-
gin. Upon disagreement, final determination of tumour
origin and histologic type of differentiation was reached
by a second reevaluation of the slides and by reevaluation
of the histopathologic and operative reports.
In the historical control group (non-standardized proto-
col), all histopathologic reports and microscopic slides
were reevaluated by a single pathologist (OPFC). The his-
topathologic factors registered in this group were tumour
origin, histopathologic type of differentiation, maximum
tumour diameter, resection margin involvement,
perineural infiltration, regional lymph node involvement,
and degree of differentiation. Only pancreatobiliary or
intestinal adenocarcinomas were included in the analysis
of histopathologic factors. R2 cases were not excluded
from the analysis in the historical control group due to
non-standardized reporting for this cohort.
Statistical analysis
Survival data was obtained from the National Registry of
Norway, updated May 30, 2007. The Kaplan-Meier
method was used to calculate curves for overall survival
and to estimate median survival. Survival curves were
compared using the log-rank test. Associations between
categorical variables were examined using Chi-square test.
Mann-Whitney test was performed to compare maximum
tumour diameter (measured as a continuous variable)
between groups of independent samples. Interobserver
agreement was estimated by Cohen's kappa and catego-
rized as poor (kappa < 0.20), fair (0.21 < kappa < 0.40),
moderate (0.41 < kappa < 0.60), substantial (0.61 < kappa
< 0.80), or almost perfect (kappa > 0.80). Cox regression
models were fitted in order to estimate univariate and
multivariable survival, together with the hazard ratios and
their 95% confidence intervals. For categorical variables,
the group with the best prognosis in univariate analysis
was set as reference. The multivariable survival model
included all histopathologic factors, and the factors were
further evaluated using stepwise variable selection. The
model obtained from multivariable analysis in periamp-
ullary adenocarcinomas was tested in the ampullary sub-
group in order to evaluate how well multivariable analysis
with the same set of covariates could predict the prognosis
in this group for which classification by histologic type of
differentiation is already established. A separate multivar-
iable Cox regression subgroup analysis was performed for
patients with pancreatobiliary differentiated periampul-
lary adenocarcinoma in order to determine the factors
that were independently associated with survival in this
subgroup. Finally, the main findings obtained from the
study group analysis were validated by analysis of his-
topathologic factors in a historical control group.
Statistical analyses were performed in SPSS 15.0 for Win-
dows software (SPSS Inc., Chicago, Illinois, USA). R ver-
sion 2.3.1 (open source statistical software [18]) was used
for testing goodness-of-fit based on martingale residual
processes. For all tests, a two-sided p < 0.05 was consid-
ered statistically significant.
Results
In the study group comprising 114 periampullary adeno-
carcinomas, there were 67 with pancreatobiliary and 47
with intestinal histologic type of differentiation. These
consisted of 40 pancreatic, 41 ampullary, 17 common bile
duct, and 16 duodenal adenocarcinomas. Interobserver
agreement between the senior and routine pathologist
was almost perfect (kappa 0.90; 95% CI 0.82–0.99) for
determination of histologic type of differentiation, while
it was only fair (kappa 0.37; 95% CI 0.25–0.49) in classi-
fication of tumour origin. However, while the routine
pathologist who reevaluated the microscopic slides was
blinded towards clinical and macroscopic data, the senior
pathologist not only reevaluated the microscopic slides
but also considered information from the operative and
macroscopic reports. This type of information may be
more important for accurate tumour origin classification
than for histologic type classification. Thus, comparing
final consensus with the original reports, interobserver
agreement was substantial for both tumour origin classifi-
cation (25 reclassified cases; kappa 0.68; 95% CI 0.57–BMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
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0.79) and histologic type classification (13 reclassified
cases; kappa 0.74; 95% CI 0.61–0.87).
Histopathologic prognostic factors in periampullary 
adenocarcinoma
As expected patients with pancreatic tumours had the
poorest prognosis among all periampullary adenocarci-
nomas in univariate analysis (p < 0.001, figure 2). Pancre-
atobiliary type of differentiation was an adverse predictor
of survival both in the whole cohort of periampullary ade-
nocarcinomas (p < 0.001, figure 3A) and in the ampullary
subgroup (p < 0.022, figure 3B).
Table 1 describes associations between histologic type of
differentiation and the other histopathologic factors.
Compared to intestinal type adenocarcinomas, pancreato-
biliary type adenocarcinomas significantly more often
showed presence of histopathologic features associated
with a poor prognosis, in particular resection margin
involvement, perineural infiltration, areas with poor dif-
ferentiation, advanced pT stage, and pancreatic tumour
origin (p < 0.001 for each).
In multivariable analysis adjusting for tumour origin, pT
stage, maximum tumour diameter, degree of differentia-
tion, regional lymph node metastasis, resection margin
involvement, vessel involvement, and perineural infiltra-
tion, the histologic type of differentiation was found to be
an independent predictor of survival (p = 0.032; HR 2.8;
95% CI 1.1–7.1), while tumour origin was only border-
line significant (p = 0.054). Stepwise backward variable
selection resulted in a final model that included the histo-
logic type of differentiation, which in fact was the strong-
est predictor of survival (table 2). The validity of the final
model was tested in the ampullary subgroup, confirming
that pancreatobiliary versus intestinal type of differentia-
tion was an independent adverse predictor of survival also
among these patients (p < 0.002; HR 4.0; 95% CI 1.6–
9.6).
Prognostic factors in pancreatobiliary differentiated 
periampullary adenocarcinomas
A separate analysis of histopathologic factors among the
patients who had pancreatobiliary adenocarcinoma (n =
67) was performed in order to identify prognostic factors
in this subgroup, and in particular, to evaluate whether
tumour origin could independently predict the prognosis
in pancreatobiliary type adenocarcinoma. In univariate
survival analysis, pancreatic tumour origin was signifi-
cantly associated with a poorer prognosis compared to
non-pancreatic tumour origin (table 3, figure 4A). Even
when adjusting for pT stage, the difference in survival
between patients who had pancreatic and non-pancreatic
tumour origin was statistically significant (p = 0.003; HR
= 2.9; 95% CI 1.4–6.0). However, adjusting for tumour
diameter instead of pT stage demonstrated that there was
in fact no survival difference between patients who had
pancreatic and non-pancreatic tumours (p = 0.25). The pT
staging for periampullary adenocarcinomas is based on
the assumption that clinical outcome depends more on
tumour extension beyond organ of origin than of tumour
size. An ampullary pT3 tumour slightly invading the pan-
creas may thus be as small as 1 cm, while pancreatic pT3
tumours are normally much larger. In the present sub-
group analysis of pancreatobiliary differentiated tumours,
pancreatic pT3 tumours were significantly larger than
non-pancreatic pT3 tumours (median diameter 3.5 versus
2.6 cm; p = 0.033).
Among all 67 pancreatobiliary differentiated adenocarci-
nomas, pancreatic tumours significantly more often than
non-pancreatic tumours had regional lymph node metas-
tasis (29/38 for pancreatic versus 12/29 for non-pancre-
atic tumours, p = 0.004) and were larger (median
diameter 3.1 cm for pancreatic versus 2.0 cm for non-pan-
creatic tumours, p < 0.001) (figure 4B). The differences in
survival seen among all cases (figure 4A) are thus related
to the differences in tumour diameter (figure 4B) between
Overall survival after pancreaticoduodenectomy for periamp- ullary adenocarcinoma (n = 114) originating in duodenum (n  = 16), ampulla (n = 41), distal bile duct (n = 17), and pancreas  (n = 40) (p < 0.001) Figure 2
Overall survival after pancreaticoduodenectomy for 
periampullary adenocarcinoma (n = 114) originating 
in duodenum (n = 16), ampulla (n = 41), distal bile 
duct (n = 17), and pancreas (n = 40) (p < 0.001).
Patients at risk
ampulla 41 32 26 23 18 14
d u o d e n u m 1 6 1 49765
distal bile duct 17 15 11 6 6 6
p a n c r e a s 4 0 2 49620BMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
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Overall survival after pancreaticoduodenectomy: (A) Periampullary adenocarcinoma (n = 114) with intestinal (n = 47) and pan- creatobiliary (n = 67) type of histologic differentiation (p < 0.001) Figure 3
Overall survival after pancreaticoduodenectomy: (A) Periampullary adenocarcinoma (n = 114) with intestinal (n = 47) 
and pancreatobiliary (n = 67) type of histologic differentiation (p < 0.001). (B) Ampullary adenocarcinoma (n = 41) with intesti-
nal (n = 28) and pancreatobiliary (n = 13) type of histologic differentiation (p = 0.02).
Patients at risk
intestinal 47 41 31 28 21 17
pancreatobiliary 67 44 24 14 11 8
Patients at risk
intestinal 28 24 20 19 14 11
pancreatobiliary 13 86443
A B Periampullary carcinoma Ampullary carcinoma
Table 1: Associations between histologic type of differentiation and other histopathologic factors in 114 periampullary 
adenocarcinomas
Differentiation of adenocarcinoma
intestinal pancreatobiliary p-valuea
Tumour origin ampulla 28 13 < 0.001
duodenum 16 0
distal bile duct 1 16
pancreas 2 38
pT stage pT1 10 2 < 0.001
pT2 20 9
pT3 8 46
pT4 9 10
Lymph node status N0 23 26 0.282
N1 24 41
Resection margin status R0 40 34 < 0.001
R1 7 33
Vessel involvement free 35 36 0.025
involved 12 31
Perineural infiltration no 35 17 < 0.001
yes 12 50
Areas with poorly differentiated tumour no 39 32 < 0.001
yes 8 35
Tumour size (maximum tumour diameter) small (≤ 2.5 cm) 31 35 0.108b
large (> 2.5 cm) 16 32
aChi-square test, when not otherwise specified
bMann-Whitney test (histologic type of differentiation vs tumour size measured as a continuous variable)BMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
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non-pancreatic and pancreatic tumours. Selecting
tumours of comparable size (range 2.0–3.0 cm, n = 30)
demonstrated no difference in survival between pancre-
atic (n = 18) and non-pancreatic cases (n = 12) (p = 0.851,
figure 4C). These groups were comparable with respect to
tumour diameter (median 2.5 and mean 2.4 cm for both
groups), and the equal survival was not due to less fre-
quent lymph node metastasis among pancreatic cases
(positive lymph nodes in 15/18 pancreatic compared to
6/12 non-pancreatic cases).
Starting with all the histopathologic factors in the base
model for multivariable analysis, backward variable selec-
tion thus resulted in a final model that did not include
tumour origin (table 3). Only lymph node status, vessel
involvement and tumour diameter independently pre-
dicted the prognosis after resection of pancreatobiliary
type periampullary adenocarcinoma. The final model
obtained from stepwise backward analysis was confirmed
by repeating variable selection with forward stepwise
analysis. Although perineural infiltration also seemed to
be an important prognostic factor in univariate analysis,
this factor did not independently predict survival, due to
a strong association with lymph node metastasis (p =
0.002), vessel involvement (p < 0.001), and tumour
diameter (p = 0.024).
Validation of main conclusions in an independent dataset
We finally validated our main findings by performing a
separate analysis of histopathologic prognostic factors in
the historical control group consisting of patients oper-
ated in our institution before standardization of his-
topathologic assessment. Among these patients, 73 and
26 were upon reevaluation of the histologic slides found
to have pancreatobiliary and intestinal differentiation,
respectively. Tumour origin for all 99 cases was classified
as ampullary (n = 23), duodenal (n = 14), distal bile duct
(n = 10), and pancreatic (n = 52).
In univariate survival analysis, pancreatobiliary type of
differentiation (p < 0.001) and pancreatic tumour origin
(pancreatic versus ampullary, p = 0.03) both predicted a
poor prognosis. Adjusting for maximum tumour diame-
ter, lymph node and resection margin involvement,
degree of differentiation, and whether there was presence
of perineural infiltration, the histologic type of differenti-
ation remained highly significant (p < 0.001; HR 2.7; 95%
CI 1.5–4.9). In contrast, although approaching signifi-
cance, tumour origin did not significantly predict the
prognosis after adjustment for these other factors (pancre-
atic versus ampullary, p = 0.10; HR 1.6; 95% CI: 0.9–2.9).
In the subgroup analysis including only pancreatobiliary
differentiated tumours (n = 73), stepwise variable selec-
tion resulted in a final multivariable model in which
Table 3: Survival analysis of histopathologic prognostic factors in pancreatobiliary resections (n = 67)
p-value
HR 95% CI Univariate Multivariable
Pancreatic tumour origin (pancreatic vs non-pancreatic) 2.3 1.3–4.0 0.004
pT stage (pT3 or pT4 vs pT1 or pT2) 2.0 0.9–4.2 0.073
Resection margin involvement (R1 vs R0) 1.7 1.0–2.8 0.052
Lymph node involvement (N1 vs N0) 3.0 1.6–5.4 < 0.001 0.007
Poor differentiation (yes vs no) 1.6 0.9–2.6 0.094
Vessel involvement (yes vs no) 3.1 1.8–5.3 < 0.001 0.035
Perineural infiltration (yes vs no) 2.8 1.4–5.5 0.003
Tumour size (continuous, measured in cm) 1.7 1.3–2.1 < 0.001 < 0.001
HR, hazard ratio. HR > 1 indicates increased probability of death
CI, confidence interval
Table 2: Multivariable Cox regression analysis of histopathologic prognostic factors in periampullary adenocarcinomas (n = 114)
HR 95% CI p-value
Histologic type pancreatobiliary (vs intestinal) 3.1 1.8–5.1 < 0.001
Lymph node involvement N1 (vs N0) 2.5 1.5–4.4 < 0.001
Vessel involvement involved (vs not involved) 1.9 1.2–3.1 0.012
Tumour size diameter (measured in cm) 1.3 1.1–1.5 0.011
HR, hazard ratio. HR > 1 indicates increased probability of death compared to the reference group (for categorical variables) or compared to each 
increase of one cm in tumour size (continuous variable)
CI, confidence intervalBMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
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Pancreaticoduodenectomy for pancreatobiliary type periampullary adenocarcinoma: (A) Univariate survival for patients with  pancreatobiliary type periampullary adenocarcinomas (n = 67) originating in ampulla (n = 13), distal bile duct (n = 16), and pan- creas (n = 38) (p = 0.009) Figure 4
Pancreaticoduodenectomy for pancreatobiliary type periampullary adenocarcinoma: (A) Univariate survival for 
patients with pancreatobiliary type periampullary adenocarcinomas (n = 67) originating in ampulla (n = 13), distal bile duct (n = 
16), and pancreas (n = 38) (p = 0.009). (B) Boxplot of maximum tumour diameter in the same 67 tumours with pancreatobil-
iary differentiation (p < 0.001, pancreatic versus non-pancreatic). (C) Survival for patients with non-pancreatic (n = 12, of which 
6 ampullary and 6 biliary) and pancreatic (n = 18) tumours of comparable size (2 cm ≤ maximum diameter ≤ 3 cm) (p = 0.851).
Patients at risk
pancreatic 18 12 6 4 1 0
non-pancreatic 12 7 4 2 2 2
Patients at risk
a m p u l l a 1 386443
distal bile duct 16 14 10 5 5 5
p a n c r e a s 3 8 2 28520
A
C
BBMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
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lymph node status (N1 versus N0, p < 0.001; HR 3.4; 95%
CI: 1.9–6.0) was confirmed to independently predict the
prognosis, adjusting for grade of differentiation (high/
moderate versus low, p = 0.002; HR 2.6; 95% CI 1.4–4.8)
and resection margin status (R1/2 versus R0, p = 0.011;
HR 1.9; 95% CI 1.2–3.2). Although significant in univar-
iate analysis (p = 0.021), tumour diameter was not con-
firmed to independently predict survival in this cohort,
possibly due to the small size of these tumours (mean
diameter 2.1 cm; 95% CI 1.9–2.4) and a significant asso-
ciation between tumour diameter and lymph node status
(p = 0.04). Finally, after stepwise variable selection,
tumour origin and perineural infiltration did not remain
in the final multivariable model evaluating histopatho-
logic factors of pancreatobiliary differentiated periampul-
lary adenocarcinomas, in accordance with the results from
the study group analysis.
Discussion
In the present study, we evaluated the prognostic impor-
tance of the two main histologic types of differentiation,
pancreatobiliary and intestinal types, in presumed cura-
tive resections for pancreatic head adenocarcinomas. We
found that the pancreatobiliary histologic type of differen-
tiation was independently associated with a poor progno-
sis, while tumour origin did not significantly predict
survival when adjusting for other histopathologic prog-
nostic factors. In pancreatobiliary type adenocarcinomas,
survival depended on factors related to the disease stage
(tumour size and regional lymph node involvement), but
not on the anatomic structure of origin. The main conclu-
sions from this study were confirmed by analysis in an
independent dataset.
For multiple reasons, we suggest that determination of the
histologic type of differentiation is a useful adjunct to
classification of the anatomical site of origin in periamp-
ullary tumours. Failure to reach a precise diagnosis of
tumour origin may lead to false assumptions regarding
long-term survival [2,7,10]. Periampullary anatomy may
be distorted by carcinoma or affected by inflammation
and fibrosis [9]. The normal ampulla, defined as the junc-
tion between the distal bile duct and the main pancreatic
duct, has a variable length and is absent in a large propor-
tion of the normal population [9]. Resected ductal pancre-
atic adenocarcinomas in the pancreatic head typically
have a mean diameter of ~3 cm[1], and may involve the
entire ampullary region [5]. Determination of tumour ori-
gin should therefore be standardized and include a sec-
tion parallel to (and including) the ductal structures in
order to evaluate the tumour's relation to the ductal anat-
omy. However, even with standardized evaluation, inter-
observer variability may be considerable unless clinical
and macroscopic data is also emphasized.
The present study is the first report on the distribution of
pancreatobiliary and intestinal type differentiation in a
cohort of resected adenocarcinomas of all periampullary
locations. With respect to ampullary tumours, it has been
known for more than a decade that these may have either
"intestinal" or "pancreatobiliary" histologic type of differ-
entiation [13], and that the intestinal type has a signifi-
cantly better prognosis [7,11-14]. Intestinal type biliary
tract [15] and pancreatic [16] carcinomas have also been
reported, but there is sparse data comparing pancreatobil-
iary type adenocarcinomas of these three different origins
[19-21]. Although many studies have compared ductal
adenocarcinomas of different periampullary origin [19-
22], most studies do not state specifically whether intesti-
nal type ampullary adenocarcinomas were excluded in
such comparisons. It should be noted that ductal adeno-
carcinoma is not synonymous with pancreatobiliary type
of histology, since it has recently been shown that ductal
pancreatic carcinomas may have features of intestinal dif-
ferentiation [16]. Pancreatobiliary ampullary carcinomas
that involve the pancreas may be indistinguishable from
pancreatobiliary pancreatic carcinomas that extend into
the ampulla [2,8], and low ratios of ampullary versus peri-
ampullary adenocarcinomas in many studies might reflect
a tendency towards misclassification of advanced pancre-
atobiliary type ampullary carcinomas as ductal pancreatic
carcinomas.
An explanation for the often reported more favourable
prognosis in non-pancreatic versus pancreatic carcinoma
could therefore be that comparison has not been strictly
limited to pancreatobiliary type adenocarcinomas. The
reason why there are prognostic differences between
equally advanced non-pancreatic and pancreatic adeno-
carcinomas may simply be that the latter more often has a
pancreatobiliary type of histologic differentiation [7].
Thus, the question whether survival differences between
pancreatic and non-pancreatic pancreatobiliary type ade-
nocarcinomas should be attributed to disease stage or
biology, or both, has not been definitely answered [2].
The present study suggests that survival differences
between periampullary adenocarcinomas of comparable
size are more dependent on the histologic type of differ-
entiation than on the anatomic origin.
In the UICC/AJCC classification of pancreatic head malig-
nancies, adenocarcinomas originating from the peri-Vate-
rian duodenum, the ampulla of Vater, the distal bile duct,
and the ductal pancreatic tissue are considered separate
entities [23,24], and the TNM staging criteria are different
for each origin. However, since adenocarcinomas arising
from the peri-Vaterian duodenum and the ampulla of
Vater may be indistinguishable [7], and since it may also
be difficult to discriminate between pancreatobiliary dif-
ferentiated ampullary and distal bile duct adenocarcino-BMC Cancer 2008, 8:170 http://www.biomedcentral.com/1471-2407/8/170
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mas [15], pT stage might be classified according to
inappropriate anatomic location. Furthermore, pT1 in
ductal pancreatic carcinoma includes tumours with maxi-
mum diameter up to 2 cm, while pT1 in ampullary carci-
nomas includes only small tumours not invading either
the duodenum (pT2) or the pancreas (pT3). A relatively
large pancreatic tumour could therefore still be at pT1
stage compared to a small ampullary tumour extending
into the duodenum, thus classified as pT2 (or even
extending into the pancreatic tissue, thus classified as
pT3). Importantly, pT stage was the factor with the lowest
p-value both in univariate and multivariable survival
analysis of all periampullary adenocarcinomas as well as
in the subgroup of pancreatobiliary differentiated adeno-
carcinomas. The present study therefore demonstrates
that individual factors related to tumour stage are more
reliable than pT (or TNM) stage group in multivariable
analysis of prognostic factors in pancreatic head carcino-
mas.
Conclusion
Pancreatobiliary versus intestinal type of differentiation
independently predicts poor prognosis after pancreati-
coduodenectomy for periampullary adenocarcinoma. In
pancreatobiliary type periampullary adenocarcinoma,
lymph node involvement, vessel involvement, and
increasing tumour diameter were adverse predictors of
survival in the present study.
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